Financials
Financial year 2025
FlocaRx from Edegem, company number BE0760942531, closed financial year 2025 with a result of € 388,676 after tax. For that financial year FlocaRx recorded a gross margin of € 568,998 and equity of € 391,676. Compared with financial year 2024, the result moved from € 216,455 to € 388,676. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.
€ 391,676
▲ 228% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 388,676
▲ 80% vs 2024
Profit after tax over the fiscal year.
€ 400,887
▲ 79% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 116,455 paid out
30 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 2,854
▲ € 2,369 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 291,320
▼ 15% vs 2024
€ 51,625 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 3,209
▲ 178% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 145,781 | € 321,027 | € 321,534 | € 568,998 | ▲ 77% |
| Profit after taxes | € 72,476 | € 204,753 | € 216,455 | € 388,676 | ▲ 80% |
| Equity | € 201,833 | € 406,585 | € 119,455 | € 391,676 | ▲ 228% |
| Total debts | € 451,832 | € 394,829 | € 445,838 | € 298,727 | ▼ 33% |
| Cash | € 102,802 | € 343,264 | € 224,277 | € 400,887 | ▲ 79% |
| Retained profit | € 198,833 | € 403,585 | € 116,455 | € 388,676 | ▲ 234% |
| Dividend | € 0 | € 0 | € 450,000 | € 116,455 | ▼ 74% |
| Bank debt | € 443,071 | € 393,187 | € 342,445 | € 291,320 | ▼ 15% |
| Balance sheet total | € 653,664 | € 801,415 | € 565,292 | € 690,403 | ▲ 22% |
Key figures of FlocaRx, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about FlocaRx the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to FlocaRx?
What happened at FlocaRx in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 388,676 (▲ 80% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Edegem. KBO
- Marguérite Faure became a director. NBB
In short
From € 72,476 profit in 2022 to € 388,676 profit in 2025.
Paid € 257,300 in corporate taxes since 2022.
Best year ever: 2025, with € 388,676 profit.
Paid out € 566,455 in dividends to the owners in total.
Management
Behind FlocaRx is Marguérite Faure. It owns 9.4% of Radiologisch Centrum itself.
Directors
According to the 2025 annual accounts
Marguérite Faure
Director
since 2021
Establishments
Establishment units
Physical locations of this company
de Burletlaan 24
2650 Edegem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- FAURE Marguérite Elisabeth(enige oprichtster) 100%
Details
- Company number
- 0760.942.531
- VAT number
- BE 0760.942.531
- Registered office
- de Burletlaan 24, 2650 Edegem
- Names & denominations
- FlocaRx
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 January 2021
- Peppol
- Active · Active since 24 Nov 2023